Global Endocrinology Drugs Market 2012-2016

Global Endocrinology Drugs Market 2012-2016

Category : Healthcare

TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Endocrinology Drugs market to grow at a CAGR of 7.58 percent over the period 2012-2016. One of the key factors contributing to this market growth is the introduction of new drugs. The Global Endocrinology Drugs market has also been witnessing the increase in market consolidation. However, the off-label use of the human growth hormone could pose a challenge to the growth of this market. 

TechNavio's report, the Global Endocrinology Drugs Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Endocrinology Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Abbott Laboratories, Eli Lilly & Co., Novartis AG, and Pfizer Inc.

The other vendors mentioned in the report are Acrux Ltd, Alacer Corp., Alcon Inc., ChemGen Corporation., Excaliard Pharmaceuticals Inc, F. Hoffmann La Roche, Facet Biotech Corporation, Ferrosan Holding A/S, FoldRx Pharmaceuticals Inc., Genoptix Inc., Janssen Pharmaceutica NV, King Pharmaceuticals Inc., Laboratório Teuto Brasileiro S.A., NextWave Pharmaceuticals Inc., Novo Nordisk A/S, Pharmacia Corporation, Piramal Healthcare Limited, Solvay Pharmaceuticals Inc., STARLIMS Technologies Ltd., and Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd.

Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

01. Executive Summary

02. Introduction

03. Market Coverage


Market Overview

Key Offerings

04. Market Landscape

Market Size and Forecast

Market Segmentation

04.1 Five Forces Analysis

05. Geographical Segmentation

06. Vendor Landscape

07. Buying Criteria

08. Market Growth Drivers

09. Drivers and their Impact

10. Market Challenges

11. Impact of Drivers and Challenges

12. Market Trends

13. Key Vendor Analysis


13.1 Pfizer Inc.

Business Overview

Key Information

SWOT Analysis

13.2 Novartis AG

Business Overview

Key Information

SWOT Analysis

13.3 Abbott Laboratories

Business Overview

Key Information

SWOT Analysis

13.4 Eli Lilly & Co.

Business Overview

Key Information

SWOT Analysis

14. Other Reports in this Series



List of Exhibits:

Exhibit 1: Global Endocrinology Drugs Market 2012–2016 (US$ billion)

Exhibit 2: Global Endocrinology Drugs Market by Segmentation

Exhibit 3: Global Endocrinology Drugs Market by Geographical Segmentation 2012

Exhibit 4: Global Endocrinology Drugs Market by Vendor Segmentation 2012


Enquiry Before Buy
image
Can´t read the image ? refresh here.